In a nutshell, Fagron is now addressing doctors as new partners in France to help them find the most appropriate personalized treatment for their patients
In Conversation
The rationale behind targeting East Asia and Central-South America first is that they are emerging markets which have mostly been ignored by big pharma
There is a strong link between health and beauty. While many diseases have a negative impact on outward appearance, treatments can also produce negative side effects…
PharmaEngine wants to be highly competitive within the industry. Building a strong and diversified portfolio is a key competency
Novartis has been present in China for the last three decades, during which we launched about 62 medicines (including different indications)
The seawater must be collected from special points in the ocean where there is a lot of phytoplankton, where the marine food chain begins. Because of…
Around the world, many countries have taken Egypt's 100 Million Seha campaign as an example of how to screen a huge part of a population and…
Our issue is that economically Catalonia is a region that excels compared to many other areas of Spain, yet the Spanish government decides and divides the…
In collaboration with the government, we started to look into possibilities on how to guarantee patient access to innovative products, which are relatively highly-priced
The [Spanish women's health market] is very competitive since there are many companies and the sector is overwhelmingly a business of midcaps
Our success is based on our people, as they allow us to do things better than our competitors and be ahead of the game
The idea is that we take the hidden gems available globally – in the areas of dermatology, medical aesthetics and other skin-related areas that affect people’s…
